Taken together, results from these inhibitor studies suggest SIRT-1 and SIRT-3 play important roles in mediating TL-induced down-regulation of CAV-1 protein expression in A549 and NCI-H460 lung cancer cells. The gene discussed is CAV1; the disease is lung carcinoma.